DeepScribe is a software company based in San Francisco, California, specializing in healthcare software solutions. Founded in 2017, the company employs between 51 and 200 individuals and has reported revenue of approximately $38.86 million. DeepScribe focuses on the application of generative AI in clinical documentation, aiming to streamline the documentation process for medical practitioners. A key aspect of their work involves developing methodologies to assess the quality of AI-generated medical notes. Their comprehensive approach includes metrics such as the Major Defect-Free Rate (MDFR) and Critical Defect-Free Rate (CDFR), which evaluate error frequencies, as well as the Captured Entity Rate (CER) and Accurate Entity Rate (AER) to measure the relevance and precision of captured medical information. Their technical report outlines the complexities involved in ensuring the accuracy and user acceptance of AI-generated documentation, highlighting the importance of continuous improvement in patient care documentation. This focus on quality assessment reflects DeepScribe’s commitment to enhancing clinical workflows through innovative software solutions.